Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Current Atherosclerosis Reports|January 8, 2025
Debate: Lipid-lowering Therapies and Diabetes DevelopmentJulia Brandts, Dirk Müller-WielandCurrent Atherosclerosis Reports|July 28, 2019
PCSK9 Inhibition: New Treatment Options and Perspectives to Lower Atherogenic Lipoprotein Particles and Cardiovascular RiskJulia Brandts, Dirk Müller-WielandHerz|August 26, 2022
[Lipid lowering: new agents and new concepts]Julia Brandts, Marlo Verket, Dirk Müller-WielandHerz|July 1, 2020
[New oral antidiabetic drugs]Dirk Müller-Wieland, Katharina Schütt, Julia Brandts, et al.European Journal of Preventive Cardiology|June 4, 2026
Lipoprotein(a) and residual cardiovascular risk in statin-treated patientsSam-Lennart Oftadeh, Andreas Pütz, Malte Jacobsen, et al.Deutsche Medizinische Wochenschrift (1946)|February 23, 2018
[Type 2 Diabetes Diabetes in Older Adults: Example for Patient-Centered Drug Therapy]Dirk Müller-WielandExpert Opinion on Therapeutic Targets|April 23, 2004
Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?Jorg Kotzka, Dirk Müller-WielandMedizinische Klinik (Munich, Germany : 1983)|December 20, 2003
[Hyperlipidemia: therapeutic principles in clinical practice]Dirk Müller-Wieland, Wilhelm KroneDeutsche Medizinische Wochenschrift (1946)|April 30, 2020
[Therapy of type 2 diabetes - Recommendations of the European Association for the Study of Diabetes (EASD)]Dirk Müller-Wieland, Nikolaus MarxMMW Fortschritte Der Medizin|December 12, 2007
[LDL cholesterol--why lower and lower?]Dirk Müller-Wieland, J KotzkaPageof 13